Home
Conditions
Myeloproliferative Neoplasm

Clinical trial condition

Myeloproliferative Neoplasm

Explore clinical trials studying Myeloproliferative Neoplasm. Study availability and eligibility vary by location and protocol.

112 public trials 37 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Neoplasm trial results

Recruiting

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

NCT07020533

Conditions: Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +38 more
Locations: City of Hope Medical Center Duarte, California, United States

Northside Hospital Atlanta, Georgia, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Recruiting

Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant

NCT04898790

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +20 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Recruiting

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

NCT06013423

Conditions: Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +37 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Recruiting

Evaluation of the Pathobiology of CALR-mutated MPN Cells

NCT06480591

Conditions: Bone Marrow Diseases, Cardiovascular Diseases, Embolism and Thrombosis, +6 more
Locations: Atrium Health Levine Cancer Charlotte, North Carolina, United States

Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Recruiting

Allo HSCT Using RIC and PTCy for Hematological Diseases

NCT05805605

Conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Biphenotypic Acute Leukemia, +54 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Recruiting

Study of Venetoclax and Azacitidine in Advanced BCR-ABL Negative Myeloproliferative Neoplasms

NCT05074355

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Recruiting

Caris Chromoseq Data Collection

NCT07680868

Conditions: Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Disease, +13 more
Locations: Caris Life Sciences Phoenix, Arizona, United States

View Trial Details

Recruiting

Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

NCT06815003

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Bone Marrow Diseases, +26 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation

NCT04024761

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +12 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation

NCT06138587

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +9 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

View Trial Details

Myeloproliferative Neoplasm

Myeloproliferative Neoplasm trial results

Related conditions